VANECK ETF TRUST - BIOTECH ETF (BBH)

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / BIOTECH ETF
Number of holders
105
Total 13F shares, excl. options
776,297
Shares change
+52,538
Total reported value, excl. options
$136,185,051
Value change
+$9,292,228
Put/Call ratio
26%
Number of buys
36
Number of sells
36
Price
$175.44

Institutional Holders of VANECK ETF TRUST - BIOTECH ETF (BBH) as of Q1 2021

As of 31 Mar 2021 VANECK ETF TRUST - BIOTECH ETF (BBH) had 105 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions held a total of 776,297 shares of stock of the company.
Largest 10 holders included GOLDMAN SACHS GROUP INC, MORGAN STANLEY, ROYAL BANK OF CANADA, Kestra Advisory Services, LLC, UBS Group AG, MURPHY CAPITAL MANAGEMENT INC, BANK OF AMERICA CORP /DE/, MOGY JOEL R INVESTMENT COUNSEL INC, LPL Financial LLC, and STIFEL FINANCIAL CORP.
This table shows 105 institutional shareholders of the security as of 31 Mar 2021.
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.